Quarterly report · Q2

Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥12.1bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥23.5bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥11.0bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income¥1.0bn2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥1.0bn2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥1.0bn2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥2.5bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.0bn2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥1.0bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥1.0bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥651m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.8bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥738m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥649m2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥748m2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥18.5bnat 2023-09-30Cons.Assets
Total assets¥17.4bnat 2023-03-31Cons.Assets
Total assets¥15.7bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥7.4bnat 2023-09-30Cons.Liabilities
Total liabilities¥6.6bnat 2023-03-31Cons.Liabilities
Net assets / equity¥11.1bnat 2023-09-30Cons.Net assets
Net assets / equity¥10.8bnat 2023-03-31Cons.Net assets
Net assets / equity¥9.9bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥7.6bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥7.2bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥7.1bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥6.8bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥7.0bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥6.5bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥929m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥1.1bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥819m2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥220m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥542m2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥86m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥409m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥281m2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥273m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥53.12023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥48.062023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥144.52022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥60.162022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥41.912022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio59.7%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio61.8%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio62.5%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥89m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥89m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥1.1bn
jpcrp040300-q2r_E05236-000Global Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥1.7bn
jpcrp040300-q2r_E05236-000Global Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥1.7bn
jpcrp040300-q2r_E05236-000Global Businessreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥34m
jpcrp040300-q2r_E05236-000Global Businessreportable segmentsegment profit2023-04-01 → 2023-09-30¥204m
jpcrp040300-q2r_E05236-000Medical Big Data Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥917m
jpcrp040300-q2r_E05236-000Medical Big Data Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥917m
jpcrp040300-q2r_E05236-000Medical Big Data Businessreportable segmentsegment profit2023-04-01 → 2023-09-30¥104m
jpcrp040300-q2r_E05236-000Package Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥2.3bn
jpcrp040300-q2r_E05236-000Package Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥2.3bn
jpcrp040300-q2r_E05236-000Package Businessreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥407,000
jpcrp040300-q2r_E05236-000Package Businessreportable segmentsegment profit2023-04-01 → 2023-09-30¥601m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥12.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥12.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-09-30¥89m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥2.1bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥89m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥89m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥852m
jpcrp040300-q2r_E05236-000Global Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥1.4bn
jpcrp040300-q2r_E05236-000Global Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥1.4bn
jpcrp040300-q2r_E05236-000Global Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥19m
jpcrp040300-q2r_E05236-000Global Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥184m
jpcrp040300-q2r_E05236-000Medical Big Data Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥719m
jpcrp040300-q2r_E05236-000Medical Big Data Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥719m
jpcrp040300-q2r_E05236-000Medical Big Data Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥71m
jpcrp040300-q2r_E05236-000Package Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥2.1bn
jpcrp040300-q2r_E05236-000Package Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥2.1bn
jpcrp040300-q2r_E05236-000Package Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥28m
jpcrp040300-q2r_E05236-000Package Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥556m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥11.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥11.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥89m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥1.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 531
ItemContextValueUnit
Number of shares heldCurrentQuarterInstant_No1MajorShareholdersMember2900200
Shareholding ratioCurrentQuarterInstant_No1MajorShareholdersMember0.2336
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember2051200
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.1652
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember1099280
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.0886
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember832700
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.0671
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember652700
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.0526
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember278640
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.0224
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember277400
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.0223
Number of shares heldCurrentQuarterInstant_No8MajorShareholdersMember193500
Shareholding ratioCurrentQuarterInstant_No8MajorShareholdersMember0.0156
Number of shares heldCurrentQuarterInstant_No9MajorShareholdersMember180400
Shareholding ratioCurrentQuarterInstant_No9MajorShareholdersMember0.0145
Number of shares heldCurrentQuarterInstant_No10MajorShareholdersMember150500
Shareholding ratioCurrentQuarterInstant_No10MajorShareholdersMember0.0121
Number of shares heldCurrentQuarterInstant8616520
Shareholding ratioCurrentQuarterInstant0.6941
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember5100
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember12409700
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember124097
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember3660
Number of shares issued shares voting rightsCurrentQuarterInstant12418460
Number of voting rights issued shares voting rightsCurrentQuarterInstant124097
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member5100
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member5100
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0004
Number of shares held in own name treasury shares etcCurrentQuarterInstant5100
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant5100
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0004
Cash and depositsPrior1YearInstant7206690000JPY
Cash and depositsCurrentQuarterInstant7551713000JPY
Notes and accounts receivable trade and contract assetsPrior1YearInstant6532385000JPY
Notes and accounts receivable trade and contract assetsCurrentQuarterInstant6405721000JPY
Merchandise and finished goodsPrior1YearInstant172554000JPY
Merchandise and finished goodsCurrentQuarterInstant498327000JPY
Work in processPrior1YearInstant100612000JPY
Work in processCurrentQuarterInstant110569000JPY
Raw materials and suppliesPrior1YearInstant8239000JPY
Raw materials and suppliesCurrentQuarterInstant4158000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass